• Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to ... ACCESS Newswire Wed, 08 Jul 2026 01:39:26 GMT
• Soleno Therapeutics (SLNO) Goldman Sachs 45th Annual Global Healthcare Conference summary Quartr Tue, 07 Jul 2026 20:24:36 GMT
• Soleno Therapeutics (SLNO) Jefferies London Healthcare Conference 2024 Summary Quartr Mon, 06 Jul 2026 19:39:32 GMT
• Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Steady Performance with Limited Upside in the Biotech Sector DirectorsTalk Interviews Mon, 06 Jul 2026 09:26:04 GMT
• bronstein, gewirtz & grossman, llc is investigating soleno therapeutics, inc. (slno) and encourages investors to connect ACCESS Newswire Sun, 05 Jul 2026 23:36:54 GMT
• soleno therapeutics inc. investors with substantial losses have o The National Law Review Sat, 04 Jul 2026 17:37:24 GMT
• soleno therapeutics withdraws european application for pws treatment Investing.com Sat, 04 Jul 2026 07:23:54 GMT
• bronstein, gewirtz & grossman, llc announces an investigation against soleno therapeutics, inc. (slno) and encourages stockholders... ACCESS Newswire Fri, 03 Jul 2026 03:22:46 GMT
• neurocrine biosciences: why i am upholding a buy rating after m&a deal for soleno (nbix) Seeking Alpha Thu, 02 Jul 2026 18:55:01 GMT
• palvella therapeutics appoints accomplished rare disease biotech executive and commercial leader matt pauls, j.d., m.b.a., to boar... The Manila Times Tue, 30 Jun 2026 11:42:23 GMT
• bronstein, gewirtz & grossman, llc initiates an investigation into allegations against soleno therapeutics, inc. (slno) and encour... ACCESS Newswire Mon, 29 Jun 2026 05:51:42 GMT
• How Soleno Therapeutics Inc. (SLNO) Affects Rotational Strategy Timing Stock Traders Daily Sun, 28 Jun 2026 23:38:02 GMT
• bronstein, gewirtz & grossman, llc encourages soleno therapeutics The National Law Review Sun, 28 Jun 2026 16:31:21 GMT
• bronstein, gewirtz & grossman, llc initiates an investigation into allegations against soleno therapeutics, inc. (slno) and encour... ACCESS Newswire Fri, 26 Jun 2026 02:13:31 GMT
• bronstein, gewirtz & grossman, llc is investigating soleno therapeutics, inc. (slno) and encourages stockholders to connect ACCESS Newswire Wed, 24 Jun 2026 00:20:05 GMT
• 2026-06-23 | bronstein, gewirtz & grossman, llc is investigating soleno therapeutics, inc. (slno) and encourages stockholders to c... Stockhouse Tue, 23 Jun 2026 15:00:00 GMT
• soleno therapeutics, inc. (slno) stock analysis: navigating the biotech sector with a strong free cash flow DirectorsTalk Interviews Mon, 22 Jun 2026 09:27:18 GMT
• bronstein, gewirtz & grossman, llc encourages soleno therapeutics, inc. (slno) shareholders to inquire about securities investigat... ACCESS Newswire Sun, 21 Jun 2026 21:24:46 GMT
• soleno therapeutics inc (slno) shareholder structure: major shareholders & institutional holdings TradingKey Sat, 20 Jun 2026 13:09:09 GMT
• soleno therapeutics inc (slno) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Sat, 20 Jun 2026 12:23:09 GMT
• bronstein, gewirtz & grossman, llc is investigating soleno therapeutics, inc. (slno) and encourages shareholders to connect ACCESS Newswire Thu, 18 Jun 2026 18:57:54 GMT
• 2026-06-18 | bronstein, gewirtz & grossman, llc is investigating soleno therapeutics, inc. (slno) and encourages shareholders to c... Stockhouse Thu, 18 Jun 2026 15:00:00 GMT
• bronstein, gewirtz & grossman, llc initiates an investigation into allegations against soleno therapeutics, inc. (slno) and encour... ACCESS Newswire Wed, 17 Jun 2026 00:26:49 GMT
• soleno therapeutics presents new vykat xr data at endo The Pharma Letter Tue, 16 Jun 2026 14:52:26 GMT
• 3-year vykat xr trial eases hyperphagia, behaviors in pws Stock Titan Mon, 15 Jun 2026 20:10:00 GMT
• soleno therapeutics announces late-breaking data at endo 2026 marketscreener.com Mon, 15 Jun 2026 20:10:00 GMT
• soleno therapeutics, inc. (slno) stock analysis: evaluating the biotech's steady trajectory DirectorsTalk Interviews Mon, 15 Jun 2026 09:24:28 GMT
• Soleno Therapeutics Presents New VYKAT® XR (diazoxide choline) Data at ENDO 2026 Demonstrating Meaningful and Durable Improvements... PR Newswire Mon, 15 Jun 2026 07:00:00 GMT
• bronstein, gewirtz & grossman, llc announces an investigation against soleno therapeutics, inc. (slno) and encourages shareholders... ACCESS Newswire Sun, 14 Jun 2026 19:20:08 GMT
• aardvark therapeutics becomes next pharma player to quit prader-willi syndrome drug development efforts Stocktwits Fri, 12 Jun 2026 06:48:30 GMT
• bronstein, gewirtz & grossman, llc announces an investigation against soleno therapeutics, inc. (slno) and encourages investors to... ACCESS Newswire Thu, 11 Jun 2026 18:48:24 GMT
• aardvark therapeutics becomes next pharma player to quit prader-willi syndrome drug development efforts Stocktwits Mon, 08 Jun 2026 22:21:30 GMT
• soleno therapeutics, inc. (slno) stock analysis: exploring the healthcare biotech leader’s steady trajectory DirectorsTalk Interviews Mon, 08 Jun 2026 07:00:00 GMT
• aardvark therapeutics becomes next pharma player to quit prader-willi syndrome drug development efforts Stocktwits Fri, 05 Jun 2026 19:12:55 GMT
• Soleno Therapeutics uses Microsoft Defender and Purview to strengthen security and governance Technology Record Thu, 04 Jun 2026 07:00:00 GMT
• neurocrine to acquire soleno therapeutics for $2.9 billion by investing.com Investing.com Australia Thu, 04 Jun 2026 07:00:00 GMT
• soleno therapeutics strengthens security and information governance with microsoft defender and purview suite for business premium... Microsoft Tue, 02 Jun 2026 23:30:59 GMT
• nbix: multi-product growth, major acquisition, and robust pipeline drive strong financial and patient impact TradingView Tue, 02 Jun 2026 17:12:15 GMT
• soleno therapeutics, inc. (slno) stock analysis: navigating zero upside but strong cash flow DirectorsTalk Interviews Mon, 01 Jun 2026 09:24:00 GMT
• bronstein, gewirtz & grossman, llc is investigating soleno therapeutics, inc. (slno) and encourages stockholders to connect ACCESS Newswire Wed, 27 May 2026 15:05:37 GMT
• soleno therapeutics (slno) investor outlook: navigating the hold ratings with promising eps and cash flow DirectorsTalk Interviews Mon, 25 May 2026 09:19:18 GMT
• soleno therapeutics, inc. (slno) investigation: bronstein, gewirtz & grossman, llc encourages stockholders to contact the firm to ... ACCESS Newswire Mon, 25 May 2026 02:32:10 GMT
• soleno therapeutics (nasdaq: slno) deregisters 3,000,000-share resale after merger Stock Titan Thu, 21 May 2026 07:00:00 GMT
• slno stockholders have opportunity to lead soleno therapeutics, inc. class action lawsuit – contact bronstein, gewirtz and grossma... ACCESS Newswire Wed, 20 May 2026 20:56:38 GMT
• soleno therapeutics, inc.(nasdaqgm:) dropped from russell small cap comp growth index marketscreener.com Tue, 19 May 2026 22:00:00 GMT
• neurocrine biosciences completes acquisition of soleno therapeutics Sahm Tue, 19 May 2026 08:19:16 GMT
• soleno therapeutics, inc.(nasdaqgm: ) dropped from russell 2500 index marketscreener.com Tue, 19 May 2026 07:00:00 GMT
• neurocrine biosciences completes $2.9 billion soleno acquisition Investing.com UK Mon, 18 May 2026 18:21:17 GMT
• soleno therapeutics announces acquisition by neurocrine biosciences and corporate changes – sec form 8-k filing Minichart Mon, 18 May 2026 14:30:00 GMT
• soleno therapeutics completes merger and delists from nasdaq TipRanks Mon, 18 May 2026 14:05:51 GMT
• neurocrine closes soleno deal, expands rare disease portfolio TipRanks Mon, 18 May 2026 14:05:51 GMT
• neurocrine biosciences (nasdaq: nbix) completes $2.9b soleno acquisition Stock Titan Mon, 18 May 2026 13:04:56 GMT
• soleno therapeutics, inc. (slno) stock report: a biotech player with steady roe and strategic focus on rare diseases DirectorsTalk Interviews Mon, 18 May 2026 09:23:44 GMT
• Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics PR Newswire Mon, 18 May 2026 07:00:00 GMT
• Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9B Contract Pharma Mon, 18 May 2026 07:00:00 GMT
• Soleno Therapeutics completes merger with Neurocrine Biosciences, delists from Nasdaq Investing.com Mon, 18 May 2026 07:00:00 GMT
• First approved Prader-Willi hunger drug changes hands in $2.9B buyout Stock Titan Mon, 18 May 2026 07:00:00 GMT
• Soleno Therapeutics (NASDAQ: SLNO) taken private at $53 per share in cash deal Stock Titan Mon, 18 May 2026 07:00:00 GMT
• Merger cashes out Soleno (NASDAQ: SLNO) officer equity at $53 Stock Titan Mon, 18 May 2026 07:00:00 GMT
• Soleno Therapeutics (SLNO) Nasdaq submits Form 25 to remove common stock Stock Titan Mon, 18 May 2026 07:00:00 GMT
• Neurocrine Biosciences: $2.9 Billion Soleno Therapeutics Acquisition Expands Rare Disease Portfolio Pulse 2.0 Mon, 18 May 2026 07:00:00 GMT
• Soleno Therapeutics (SLNO) director exits as $53-per-share cash merger closes Stock Titan Mon, 18 May 2026 07:00:00 GMT
• neurocrine closes $2.9 billion soleno acquisition to expand rare disease portfolio citybiz Mon, 18 May 2026 07:00:00 GMT
• soleno therapeutics (slno) director’s shares and options cancelled for $53 cash in neurocrine merger Stock Titan Mon, 18 May 2026 07:00:00 GMT
• soleno therapeutics (nasdaq: slno) deregisters s-3 after neurocrine merger Stock Titan Mon, 18 May 2026 07:00:00 GMT
• soleno (slno) director’s shares cashed out at $53 per-share merger price Stock Titan Mon, 18 May 2026 07:00:00 GMT
• soleno therapeutics (slno) director equity canceled in $53-per-share merger Stock Titan Mon, 18 May 2026 07:00:00 GMT
• soleno therapeutics (slno) cbo equity canceled, cashed out at $53 per share Stock Titan Mon, 18 May 2026 07:00:00 GMT
• soleno therapeutics (slno) insider equity cashed out at $53 in neocrine merger Stock Titan Mon, 18 May 2026 07:00:00 GMT
• neurocrine completes soleno buyout (nasdaq: slno) at $53.00 per share Stock Titan Mon, 18 May 2026 07:00:00 GMT
• neurocrine (slno) completes tender offer; ~46.36m soleno shares tendered Stock Titan Mon, 18 May 2026 07:00:00 GMT
• soleno therapeutics (slno) cco equity cancelled, converted to $53 cash in merger Stock Titan Mon, 18 May 2026 07:00:00 GMT
• neurocrine biosciences, inc. completed the acquisition of soleno therapeutics, inc. from anish bhatnagar, james mackaness, and oth... marketscreener.com Mon, 18 May 2026 07:00:00 GMT
• press release: neurocrine biosciences completes acquisition of soleno therapeutics Moomoo Mon, 18 May 2026 07:00:00 GMT
• neurocrine biosciences finalizes $2.9 billion acquisition of soleno therapeutics Moomoo Mon, 18 May 2026 07:00:00 GMT
• soleno therapeutics (slno) cfo has rsus and stock options cashed out in neocrine merger Stock Titan Mon, 18 May 2026 07:00:00 GMT
• soleno therapeutics (slno) ceo fully cashed out as $53-per-share merger closes Stock Titan Mon, 18 May 2026 07:00:00 GMT
• soleno therapeutics (slno) cdo equity cancelled for $53 cash in merger Stock Titan Mon, 18 May 2026 07:00:00 GMT
• soleno (slno) director’s 10,046 rsus canceled for $53 cash in merger Stock Titan Mon, 18 May 2026 07:00:00 GMT
• soleno (slno) svp exits equity as merger pays $53 per share Stock Titan Mon, 18 May 2026 07:00:00 GMT
• neurocrine completes $2.9b acquisition of solen... | pluang – crypto, stocks, gold & funds Pluang Mon, 18 May 2026 07:00:00 GMT
• soleno therapeutics, inc.(nasdaqcm:slno) dropped from s&p biotechnology select industry index marketscreener.com Mon, 18 May 2026 00:38:17 GMT
• soleno therapeutics, inc.(nasdaqcm:slno) dropped from s&p biotechnology select industry index marketscreener.com Sun, 17 May 2026 07:00:00 GMT
• the technical signals behind (slno) that institutions follow Stock Traders Daily Fri, 15 May 2026 18:40:02 GMT
• wellington affiliates disclose 8.57% stake in soleno therapeutics (slno) Stock Titan Fri, 15 May 2026 11:06:01 GMT
• t. rowe price (nasdaq: slno) reports 1,025,868 shares, 2.0% stake Stock Titan Fri, 15 May 2026 07:00:00 GMT
• avoro and aghazadeh report 4.45% stake in soleno (nasdaq: slno) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• state street (slno) holds 2.68m shares, 5.2% stake in soleno therapeutics Stock Titan Tue, 12 May 2026 07:00:00 GMT
• soleno therapeutics, inc. (slno) stock analysis: a strategic hold in the biotech space with steady potential DirectorsTalk Interviews Mon, 11 May 2026 09:26:06 GMT
• SLNO 8-DAY DEADLINE ALERT: Hagens Berman Alerts Soleno Therapeutics (SLNO) Investors to Securities Class Action Alleging Hyperphag... PR Newswire Mon, 11 May 2026 07:00:00 GMT
• Soleno Therapeutics faces final earnings test before buyout Investing.com Mon, 11 May 2026 07:00:00 GMT
• soleno therapeutics faces class action over alleged safety cover-ups and inflated drug launch claims. Pluang Mon, 11 May 2026 07:00:00 GMT
• soleno merger with neurocrine puts profitability and valuation in focus Yahoo Finance Mon, 11 May 2026 03:14:00 GMT
• neurocrine reaffirms $2.7b-$2.8b ingrezza outlook while acquisition of soleno remains on track for q2 close MSN Sun, 10 May 2026 19:05:03 GMT
• number of shareholders of soleno therapeutics, inc. – nasdaq:slno TradingView Sun, 10 May 2026 08:31:45 GMT
• Soleno Merger With Neurocrine Puts Profitability And Valuation In Focus Yahoo Finance Sun, 10 May 2026 07:00:00 GMT
• Lobbying Update: $80,000 of SOLENO THERAPEUTICS INC. lobbying was just disclosed Quiver Quantitative Sat, 09 May 2026 07:00:00 GMT
• soleno therapeutics (slno) q4 profitability jump tests longstanding bearish earnings narratives Sahm Sat, 09 May 2026 07:00:00 GMT
• neurocrine biosciences stock (us62886e1082): analysts lift price targets after strong q1 2026 result AD HOC NEWS Fri, 08 May 2026 20:32:53 GMT
• soleno therapeutics, inc. q1 2026 financial results and sec 10-q filing overview Minichart Fri, 08 May 2026 17:44:00 GMT
• soleno therapeutics inc reports results for the quarter ended march 31 - earnings summary TradingView Fri, 08 May 2026 02:19:00 GMT
• soleno therapeutics : quarterly report for quarter ending march 31, 2026 (form 10-q) marketscreener.com Thu, 07 May 2026 23:08:36 GMT
• soleno therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Thu, 07 May 2026 20:45:00 GMT
• is it time to reassess soleno therapeutics (slno) after a 10x three year surge? simplywall.st Thu, 07 May 2026 19:49:25 GMT
• a look at soleno therapeutics (slno) valuation after recent share momentum and vykat xr launch progress Sahm Thu, 07 May 2026 16:55:30 GMT
• soleno therapeutics (nasdaq: slno) turns profitable and agrees $53 cash takeover Stock Titan Thu, 07 May 2026 07:00:00 GMT
• fmr llc amends 13g/a: soleno therapeutics (nasdaq: slno) 0.4% stake Stock Titan Thu, 07 May 2026 07:00:00 GMT
• janus henderson group (slno) reports 1.21m-share, 2.3% position Stock Titan Thu, 07 May 2026 07:00:00 GMT
• slno investor alert: bronstein, gewirtz and grossman, llc announces that soleno therapeutics, inc. stockholders with losses have o... ACCESS Newswire Wed, 06 May 2026 15:48:41 GMT
• neurocrine biosciences: core business on track, soleno deal adds risky upside Seeking Alpha Wed, 06 May 2026 07:00:00 GMT
• a look at soleno therapeutics (slno) valuation after recent share momentum and vykat xr launch progress simplywall.st Wed, 06 May 2026 07:00:00 GMT
• fmr llc increases reported stake in soleno therapeutics (nasdaq: slno) Stock Titan Wed, 06 May 2026 07:00:00 GMT
• neurocrine reaffirms $2.7b-$2.8b ingrezza outlook while acquisition of soleno remains on track for q2 close MSN Wed, 06 May 2026 03:01:24 GMT
• soleno deadline today: rosen, trusted investor counsel, encourages soleno therapeutics, inc. investors to secure counsel before im... TMX Newsfile Wed, 06 May 2026 02:51:00 GMT
• neurocrine biosciences (nbix) posts strong q1 2026 results and plans $2.9b soleno deal Stock Titan Tue, 05 May 2026 20:02:58 GMT
• neurocrine pairs $811m quarter with $2.9b soleno deal for rare-disease drug Stock Titan Tue, 05 May 2026 20:01:00 GMT
• brodsky & smith shareholder update: notifying investors of GlobeNewswire Tue, 05 May 2026 18:33:06 GMT
• neurocrine in the spotlight: can growth justify soleno bet? by investing.com Investing.com Nigeria Tue, 05 May 2026 17:31:32 GMT
• deadline alert for eose, slno, and nktr: the law offices of GlobeNewswire Tue, 05 May 2026 15:45:00 GMT
• slno deadline - final reminder: bronstein, gewirtz & grossman llc alerts soleno therapeutics, inc. investors to participate in the... ACCESS Newswire Tue, 05 May 2026 13:29:36 GMT
• portnoy law firm announces class action on behalf of soleno therapeutics, inc. investors GlobeNewswire Tue, 05 May 2026 13:00:00 GMT
• SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross La... Morningstar Tue, 05 May 2026 07:00:00 GMT
• SLNO DEADLINE ALERT: Hagens Berman Alerts Soleno Therapeutics (SLNO) Investors to Today's Lead Plaintiff Deadline in Securities Cl... PR Newswire Tue, 05 May 2026 07:00:00 GMT
• slno 4-day deadline alert: hagens berman alerts soleno therapeuti The National Law Review Tue, 05 May 2026 07:00:00 GMT
• slno investor notice: faruqi & faruqi, llp reminds soleno therapeutics (slno) investors of securities class action deadline on may... Morningstar Tue, 05 May 2026 07:00:00 GMT
• the gross law firm reminds soleno therapeutics, inc. investors of the pending class action lawsuit with a lead plaintiff deadline ... PR Newswire Tue, 05 May 2026 07:00:00 GMT
• slno shareholder alert: may 5, 2026 lead plaintiff deadline in soleno therapeutics, inc. securities class action lawsuit -- the gr... PR Newswire Tue, 05 May 2026 07:00:00 GMT
• soleno therapeutics, inc. class action lawsuit: investors face may 5, 2026, deadline PR Newswire Tue, 05 May 2026 07:00:00 GMT
• soleno therapeutics, inc. notice of may 5, 2026 application deadline for class action lawsuit - contact lewis kahn, esq. at kahn s... PR Newswire Tue, 05 May 2026 07:00:00 GMT
• investor alert: pomerantz law firm reminds investors with losses on their investment in soleno therapeutics, inc. of class action ... ChartMill Tue, 05 May 2026 07:00:00 GMT
• big q1 2026 jump as neurocrine (nasdaq: nbix) inks $2.9b soleno buy Stock Titan Tue, 05 May 2026 07:00:00 GMT
• soleno therapeutics 24 hour deadline alert: kahn swick & foti, llc reminds investors with losses in excess of $100,000 of deadline... ACCESS Newswire Tue, 05 May 2026 06:33:32 GMT
Soleno Therapeutics, Inc(NASDAQ:SLNO) 
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release (DCCR), a once-daily oral tablet for the treatment of Prader-Wi...
Website: http://www.soleno.life
Founded: 1999
Full Time Employees: 13
Sector: Healthcare
Industry: Diagnostics & Research